Irritable Bowel Syndrome News

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS with constipation and chronic idiopathic constipation; treatment options and recent therapeutic advances; health disparities; and important challenges of care.

More than half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported waiting at least a year before mentioning their irritable bowel syndrome symptoms to a health care provider.

Infection with SARS-CoV-2 increased the risk for long-term gastrointestinal problems within 1 year, including motility disorders, acute pancreatitis and liver disease, according to a study published in Nature Communications.

In a Healio video exclusive, Sam Jactel, CEO and founder of Ayble Health, highlights how the symptom management mobile app could improve quality of life for patients with chronic gastrointestinal conditions.

WASHINGTON — College athletes frequently reported irritable bowel syndrome and gastrointestinal distress, which were linked to sports performance anxiety and fear of food, according to a poster presented here.

Travel is a common part of life that we often take for granted — from simple acts of running errands and commuting to work to the bigger trips of visiting out-of-state loved ones and experiencing life-changing moments of world travel.

Hospitalized patients with COVID-19 had a “modest increased risk” for long-term gastrointestinal symptoms and irritable bowel syndrome compared with control patients, according to research published in Gut.

Despite affecting nearly 10% of the population, irritable bowel syndrome remains highly stigmatized. During IBS Awareness Month, a gastrointestinal disease advocacy group has launched the #YouandIBS campaign to confront this stigma head on.

Colesevelam was superior to placebo in inducing remission in patients with bile acid diarrhea with no serious adverse events reported, according to results published in The Lancet Gastroenterology & Hepatology.